[A double-blind crossover trial of alizapride versus placebo regarding effectiveness against nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].
D000328:Adult; D000368:Aged; D000932:Antiemetics / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D011759:Pyrrolidines / Q000008:administration & dosage*; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000932:Antiemetics; D000970:Antineoplastic Agents; D011759:Pyrrolidines; C033968:alizapride
Etude en double insu croisé alizapride-placebo sur la prévention des nausées et des vomissements induits par la chimiothérapie antimitotique.